In a landmark move, Danish pharmaceutical giant Novo Nordisk is set to inject a substantial €2.1 billion into its existing facility in Chartres, heralding a strategic alliance with French ...

Novo Nordisk's weight loss drug Wegovy will be available in France from Tuesday. The drug will require a prescription and will not be covered by social security.

Novo Nordisk landed in hot water with the FDA following an inspection at one of the drugmaker’s key semaglutide and insulin manufacturing plants this past spring. | The FDA issued a ...

Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted Wednesday strong third-quarter earnings despite being held back by ...

Danish pharmaceutical giant Novo Nordisk sees a significant increase in profits and sales despite production constraints.

France, and Argentina. UVA and Novo Nordisk will initially dedicate around 15 employees to the collaboration and expect the support to grow as the research develops. Kenneth Strømdahl ...

3️⃣ Poignant postcard: In 1912, a first-class passenger on the Titanic scrawled a message in pencil to someone back home in ...

15% in France, and 17% in Germany." Then there are operational problems, In 2022 Novo Nordisk had trouble meeting the huge demand for Wegovy. In December 2023 its shares were marked down because ...

For U.S. investors who are worried that domestic stocks are overheated and have gotten too expensive, the iShares Core MSCI ...

Novo Nordisk has embarked on an aggressive expansion plan across Denmark and the US, as well as in other countries such as Algeria, Brazil, China, France, Iran, Japan and Russia. “We don’t ...

Italian payments group Nexi on Friday reported third-quarter revenue above expectations and confirmed its guidance despite a ...

Novo Nordisk is ramping up its manufacturing sites ... which has been approved for use to treat obesity in Britain, Denmark, France, Germany, Norway and the United States, rose by 42 percent ...